# Effectiveness And Impact Of Nirsevimab In Chile (NIRSE-CL)

> **NCT06511687** · — · RECRUITING · sponsor: **Instituto Sistemas Complejos de Ingeniería** · enrollment: 160000 (estimated)

## Conditions studied

- RSV

## Interventions

- **BIOLOGICAL:** Nirsevimab

## Key facts

- **NCT ID:** NCT06511687
- **Lead sponsor:** Instituto Sistemas Complejos de Ingeniería
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2024-04-01
- **Primary completion:** 2024-10-01
- **Final completion:** 2024-10-01
- **Target enrollment:** 160000 (ESTIMATED)
- **Last updated:** 2024-07-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06511687

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06511687, "Effectiveness And Impact Of Nirsevimab In Chile (NIRSE-CL)". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT06511687. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*